SynthesisOpen heart2025

Efficacy of cardiac myosin inhibitors mavacamten and aficamten in hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials.

Ayesha Aman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.